Century Therapeutics cuts CSO Chad Cowan salary to $296,150 under amended employment agreement

Century Therapeutics, Inc.

Century Therapeutics, Inc.

IPSC

0.00
  • Century Therapeutics entered an amended and restated employment agreement with Chief Scientific Officer Chad Cowan on June 15, 2026.
  • Cowan will continue in the role on a part-time basis at a reduced annual salary of 296,150.
  • Eligible for an annual performance-based target bonus on a pro-rated basis.
  • Termination or resignation triggers payment of accrued and unpaid base salary through the cessation date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Century Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-074577), on June 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.